when using antiarrhythmic drugs , a quantitative ventricular arrhythmia baseline for both frequency and type of arrhythmia must be established so that after therapeutic intervention repeat holter monitoring can determine whether efficacy , inefficacy or proarrhythmia had occurred .
C0085612
ventricular arrhythmia
C0003811
arrhythmia